Virtual engagements – or at the very least hybrid meetings – are here to stay. Face-to-face access to healthcare professionals is expected to remain difficult even after the pandemic ends, and, in the interim, pharmaceutical companies have been working to repurpose their content for full virtual engagements.
Digital change across the life sciences industry has been happening at a massively accelerated pace, buoyed by convenience, technology, and above all, the need to socially distance during the Covid-19 pandemic.
This week, I thought I would talk about the concerns that we are witnessing in the medical education arena.
While some meetings and conferences are being postponed until physical sessions can return, the show must go on with medical education.